Literature DB >> 9138108

Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae.

H A Harima1, N F Mendes, E M Mamizuka, M Mariano.   

Abstract

Glucan is a polysaccharide from the yeast Saccharomyces cerevisiae that stimulates the mononuclear phagocytic system (MPS). NZB/NZW F1 mice were divided into two groups: one group received a subcutaneous injection of 0.5 mg glucan/animal for 1 week, and the other received the same dose for 3 months. No changes were observed in those animals submitted to short-term glucan treatment, whereas animals with active lupus and submitted to long-term glucan administration presented early death, with significant differences in accumulated mortality rates over 33-37 weeks, when compared to controls. No deaths were observed in lupus mice treated with glucan 24 hours before the induction of septic shock by Klebsiella pneumoniae, in contrast to mortality of 95.3% in the control group during the follow-up period of 12 days. We conclude that although glucan is able to exacerbate lupus activity, it enhances resistance to infection in lupus mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138108      PMCID: PMC6760704     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  24 in total

1.  ANTINUCLEAR FACTOR IN MICE.

Authors:  L C NORINS; M C HOLMES
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

2.  RETICULOENDOTHELIAL FUNCTION AND THE IMMUNE RESPONSE.

Authors:  W R WOOLES; N R DILUZIO
Journal:  Science       Date:  1963-11-22       Impact factor: 47.728

3.  Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms.

Authors:  J Franĕk; J Malina; H Krátká
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

Review 4.  Modification of diverse experimental immunosuppressive states by glucan.

Authors:  N R Di Luzio; D L Williams; E R Sherwood; I W Browder
Journal:  Surv Immunol Res       Date:  1985

5.  Immunization of mice against Leishmania donovani by subcutaneous injections of dead promastigotes.

Authors:  T W Holbrook; J A Cook
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

6.  Glucan-induced enhancement of host resistance to selected infectious diseases.

Authors:  J A Reynolds; M D Kastello; D G Harrington; C L Crabbs; C J Peters; J V Jemski; G H Scott; N R Di Luzio
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

7.  Genetic and molecular genetic studies of murine and human lupus.

Authors:  A D Steinberg; D M Klinman; D L Kastner; M F Seldin; W C Gause; C L Scribner; J L Britten; J N Siegel; J D Mountz
Journal:  J Rheumatol Suppl       Date:  1987-06

8.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.

Authors:  C O Jacob; H O McDevitt
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

9.  The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.

Authors:  A D Steinberg; S Baron; N Talal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

10.  Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice.

Authors:  P J Staples; N Talal
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.